A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia

OBJECTIVES—The primary objective was to investigate the safety of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of very low birthweight infants (VLBW) with sepsis and relative neutropenia, specifically with regard to worsening of respiratory distress and thrombo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Russell, A, Emmerson, A, Wilkinson, N, Chant, T, Sweet, D, Halliday, H, Holland, B, Davies, E
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2001
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1721238/
https://ncbi.nlm.nih.gov/pubmed/11320043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/fn.84.3.F172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados